Market cap
$730 Mln
Revenue (TTM)
$586 Mln
P/E Ratio
13.2
P/B Ratio
3.1
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -7.03 | 2.73 | 3.87 | 5.22 | 7.97 |
| EBIT | -48.82 | -8.58 | 37.19 | 35.57 | 16.73 |
| Net Profit | -83.33 | 122.01 | 737.18 | 29.81 | -22.31 |
| EPS | -82.51 | 80.20 | 623.95 | 31.57 | 8.30 |
| Book Value | -- | -- | 18.19 | -20.17 | -6.67 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -2.77 | -8.08 | 9.83 | 9.19 | -1.80 |
| Net Margin
| -- | 4.53 | 9.78 | -- | -- |
| Return on equity
| -23.27 | -20.77 | 23.41 | 13.69 | -20.86 |
| Return on Capital
| -8.52 | -8.50 | -- | 4.64 | -6.38 |
| Return on Assets
| -5.15 | -5.08 | 6.76 | 3.22 | -4.36 |
| Debt to Equity (x)
| -- | -- | 0.88 | 1.69 | 2.27 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
--
|
4.64
|
-6.38
|
-23.82
|
-20.35
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
23.41
Higher than Peers by 16.90
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
23.41
|
13.69
|
-20.86
|
-62.64
|
-40.48
|
|
Peer Median
|
6.51
|
--
|
--
|
--
|
--
|
ROA
6.76
Higher than Peers by 3.80
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
6.76
|
3.22
|
-4.36
|
-14.31
|
-12.21
|
|
Peer Median
|
2.96
|
--
|
--
|
--
|
--
|
EBIT Margin
9.83
Lower than Peers by 0.85
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
9.83
|
9.19
|
-1.80
|
-15.70
|
-34.56
|
|
Peer Median
|
10.69
|
--
|
--
|
--
|
--
|
Net Margin
9.78
Higher than Peers by 2.79
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
9.78
|
4.00
|
-5.85
|
-30.49
|
-30.99
|
|
Peer Median
|
6.99
|
--
|
--
|
--
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
3.87
Lower than Peers by 5.39
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
3.87
|
-0.01
|
0.12
|
0.00
|
0.19
|
|
Peer Median
|
9.26
|
--
|
--
|
--
|
--
|
EBIT Growth
37.19
Higher than Peers by 24.42
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
37.19
|
605.08
|
87.15
|
54.56
|
-1,769.85
|
|
Peer Median
|
12.76
|
--
|
--
|
--
|
--
|
Net Profit Growth
737.18
Higher than Peers by 723.35
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
737.18
|
167.77
|
78.53
|
1.56
|
-919.12
|
|
Peer Median
|
13.83
|
--
|
--
|
--
|
--
|
EPS Growth
623.95
Higher than Peers by 603.45
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
623.95
|
1.64
|
0.79
|
0.03
|
-8.24
|
|
Peer Median
|
20.51
|
--
|
--
|
--
|
--
|
Book Value Growth
37.49
Higher than Peers by 29.41
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
37.49
|
--
|
--
|
--
|
--
|
|
Peer Median
|
8.09
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.88
Higher than Peers by 0.51
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
0.88
|
1.69
|
2.27
|
2.27
|
1.29
|
|
Peer Median
|
0.37
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.10
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
0.10
|
0.10
|
0.18
|
0.16
|
0.10
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.68
Lower than Peers by 1.14
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
1.68
|
1.70
|
1.31
|
1.53
|
0.90
|
|
Peer Median
|
2.82
|
--
|
--
|
--
|
--
|
Quick Ratio
1.16
Lower than Peers by 0.93
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
1.16
|
1.19
|
0.87
|
1.01
|
0.62
|
|
Peer Median
|
2.09
|
--
|
--
|
--
|
--
|
Interest Coverage
3.30
Lower than Peers by 2.82
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
3.30
|
1.97
|
-0.27
|
-1.98
|
-14.72
|
|
Peer Median
|
6.12
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
23.60
Higher than Peers by 7.18
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
23.60
|
22.59
|
22.22
|
23.97
|
26.61
|
|
Peer Median
|
16.42
|
--
|
--
|
--
|
--
|
Asset Turnover
0.69
Higher than Peers by 0.19
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
0.69
|
0.80
|
0.75
|
0.47
|
0.39
|
|
Peer Median
|
0.50
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
--
|
82.20
|
79.70
|
92.35
|
93.17
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
--
|
171.86
|
181.40
|
174.64
|
147.74
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
--
|
34.05
|
46.11
|
59.24
|
54.08
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
--
|
220.00
|
214.98
|
207.75
|
186.82
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
13.16
Lower than Peers by 33.00
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
13.16
|
22.56
|
-20.49
|
-2.13
|
-1.02
|
|
Peer Median
|
46.16
|
--
|
--
|
--
|
--
|
Price / Book Value
3.09
Lower than Peers by 1.79
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
3.09
|
2.78
|
4.65
|
1.91
|
0.50
|
|
Peer Median
|
4.88
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
9.27
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
9.27
|
7.79
|
25.02
|
-29.91
|
-4.52
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
730
Higher than Peers by 66
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Bioventus Inc. Class A (BVS)
|
730
|
--
|
--
|
--
|
--
|
|
Peer Median
|
664
|
--
|
--
|
--
|
--
|